Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124186003 | 12418600 | 3 | F | 2008 | 20160822 | 20160531 | 20160829 | EXP | JP-ROCHE-1765287 | ROCHE | 79.00 | YR | M | Y | 0.00000 | 20160829 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124186003 | 12418600 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 5 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | UNK | U | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
| 124186003 | 12418600 | 7 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | SOLUTION FOR INJECTION | |||||||||
| 124186003 | 12418600 | 8 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 0 | 6 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 9 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 0 | 6 | MG | SOLUTION FOR INJECTION | |||||||
| 124186003 | 12418600 | 10 | SS | VISUDYNE | VERTEPORFIN | 1 | Intravenous (not otherwise specified) | U | 0 | 6 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124186003 | 12418600 | 1 | Age-related macular degeneration |
| 124186003 | 12418600 | 2 | Retinal haemorrhage |
| 124186003 | 12418600 | 3 | Macular oedema |
| 124186003 | 12418600 | 8 | Age-related macular degeneration |
| 124186003 | 12418600 | 9 | Age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124186003 | 12418600 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124186003 | 12418600 | Macular hole | |
| 124186003 | 12418600 | Macular oedema | |
| 124186003 | 12418600 | Retinal haemorrhage | |
| 124186003 | 12418600 | Retinal scar | |
| 124186003 | 12418600 | Vitreous haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124186003 | 12418600 | 1 | 201004 | 0 | ||
| 124186003 | 12418600 | 2 | 201006 | 0 | ||
| 124186003 | 12418600 | 3 | 201007 | 0 | ||
| 124186003 | 12418600 | 4 | 201501 | 0 | ||
| 124186003 | 12418600 | 5 | 201508 | 0 | ||
| 124186003 | 12418600 | 6 | 2008 | 0 | ||
| 124186003 | 12418600 | 7 | 20110411 | 0 | ||
| 124186003 | 12418600 | 8 | 2008 | 0 | ||
| 124186003 | 12418600 | 9 | 201004 | 0 | ||
| 124186003 | 12418600 | 10 | 20110411 | 0 |